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Abstract
In a large study, published in this issue of Breast Cancer Research,
Le and colleagues report that women receiving implants after
mastectomies for early-stage breast cancer experience lower breast
cancer mortality than women not receiving implants. Assessment of
survival patterns among women receiving reconstructive implants is
complex given unique patient characteristics, disease attributes,
and treatment patterns. The interpretation of reduced mortality from
breast cancer must be assessed in light of significantly reduced
risks of death from most other causes. In contrast, patients
receiving post-mastectomy implants had elevated rates of suicide,
consistent with findings among women with cosmetic implants.
Additional well-designed investigations are needed to clarify survival
patterns among women receiving reconstructive implants.
Introduction
In this issue of Breast Cancer Research, Le and colleagues
[1] report on an important issue, namely the survival
experience of women receiving breast implants after
mastectomies for early-stage breast cancer. Although the
long-term health effects associated with cosmetic breast
implants have been extensively debated, less attention has
focused on reconstructive implants [2]. Clarification of
effects is important, given the impaired survival of women
with breast cancer and the fact that increasing numbers of
women are choosing reconstruction to improve their quality
of life after mastectomy.
Complexities of interpreting data
In an investigation that had several strengths, including a
relatively large size, a focus on a nationally representative
group of patients, long-term follow-up and available
information on types of implants, it was found that one-fifth
of women diagnosed with early-stage breast cancers
received post-mastectomy implants. Although these
women were found to have a significantly lower all-cause
mortality and lower mortality from breast cancer, the
interpretation of these relationships is complex,
necessitating an evaluation of both the characteristics of
the women who decide to seek reconstructive surgery and
the effects of medical factors associated with their
diagnoses. The authors discuss limitations of their data,
but there is in fact substantial evidence that several of
these might have seriously hindered the true interpretation
of the effects of reconstructive implants.
Patient characteristics
It is notable that only a limited amount of information was
available on patient characteristics associated with the
seeking of implants. It was clear from information
presented that women who obtained implants had several
unique attributes. Notably, they tended to be younger and
non-Hispanic whites, which is consistent with
observations made elsewhere about unique attributes of
women obtaining reconstructive surgery [3–5]. Although it
was possible in analyses to account for both age and
race, of concern was the inability of the study to adjust
completely for two major lifestyle predictors of breast
cancer prognosis, namely socioeconomic status and body
size. The investigators found no evidence that adjustment
for census-level socioeconomic indicators in the San
Francisco Bay area affected risks, but this indicator only
crudely measures socioeconomic class. Evidence that
higher family income is a significant predictor of whether a
woman decides to seek reconstructive surgery [4]
emphasizes the need for careful control for associated
parameters. Similarly, an inability to account for obesity,
also associated with poor survival from breast cancer [6],
limits interpretation of the results. Although this factor has
not been extensively examined in relation to reconstructive
surgery, it is well recognized that women who seek
cosmetic implants tend to be thin [7–9]. Inabilities to adjust
for both higher socioeconomic status and lower body
mass could have resulted in attenuations in both overall
and breast cancer mortality among women with implants.
Differences in disease attributes
Attention must also focus upon effects of differences in
disease attributes between implanted and non-implanted
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women. Notably, the proportion of in situ breast cancers
was twice as high in women with breast implants, and
women with implants were less likely to be diagnosed with
more than one primary tumor. Attempts to adjust for stage
of disease might not have adequately accounted for
important disease differences, because it is well
recognized that the decision regarding whether to seek
implants is a complex one that is often closely associated
with close access to a physician and his or her opinion as
to the advisability of the procedure [3,10,11]. Thus, if
women with only the most seemingly favorable prognoses
had been advised to seek reconstruction, the results could
have been significantly biased toward the favorable
prognostic findings reported.
Treatment effects
Given that another key prognostic factor is therapy,
consideration must also be given to whether there were
differential treatment effects between implanted and non-
implanted women. Only limited treatment information was
available. Findings elsewhere that patients seeking
reconstructive surgery are more likely to be treated at
National Cancer Institute-designated cancer centers [4]
suggests that quality-of-care issues might have important
contributory effects. This might particularly affect in situ
cancers, because the approach to treatment for these
tumors (especially ductal carcinomas) has been shown to
vary substantially across clinical settings [12]. Results
from Le and colleagues’ data indicating that reconstructive
patients were less likely to receive radiation therapy also
support the notion of differential treatment effects. This
finding is not surprising, given that immediate breast
reconstruction can interfere with post-mastectomy
radiation therapy and that post-mastectomy radiation can
adversely affect the aesthetic outcome of an immediate
breast reconstruction [13]. Given the myriad of other
subtle differences that can affect the treatment course for
patients, it might be impossible to completely control for
treatment effects within the context of an observational
study, as has been reported by Le and colleagues [1].
Thus, a more desirable approach to assessing the long-
term effects of reconstructive surgery might be within the
context of a clinical trial, where treatment effects can be
more fully taken into account.
Other methodologic limitations
Finally, the results of the study must be interpreted in the
light of some other methodologic limitations, including
losses due to questionnaire non-response and lack of
follow-up information, necessitating the evaluation of
mortality for only three-quarters of the total series of
women identified for study. In addition, it was necessary
for deceased study subjects that information on implant
status be obtained from the next-of-kin. Although the
investigators used different methods of accruing person-
years to assess the effects of missing and imprecise
information, whether selection biases could have affected
the results remains of concern.
Noncancer causes of death
That the limitations in the available data might have
seriously affected the results of the study is emphasized by
findings that women with implants were at a lowered risk of
most causes of death. Of note was the significantly
reduced risk of death for cardiovascular events. The
mortality findings are for the most part consistent with those
observed in patients with cosmetic implants, when
comparisons are made with the general population
[14–16]. However, when the mortality experience of
patients with cosmetic implants has been compared with
that of patients seeking other types of plastic surgery, few
differences have been observed, suggesting that
individuals seeking plastic surgery are consistently healthier
than other women [14]. Similarly, the decrease in nearly all
causes of death in Le and colleagues’ study suggests that
patients receiving reconstructive implants are not
comparable with the general population, requiring that extra
caution be exercised in interpreting results. In view of this, it
seems premature that the paper discusses biologic
mechanisms that could lead to a survival advantage for
breast cancer in women with reconstructive implants.
Suicide excess
In contrast to the reduced risk of most causes of death
was an excess risk of suicide among women receiving
reconstructive surgery. Although several studies have now
documented a similar excess risk of suicide among
women receiving cosmetic implants [14,15,17], this is the
first report of the relationship also extending to women
receiving reconstructive implants. It is unclear why women
with cosmetic implants have higher rates of suicide,
although predisposing personality characteristics have
been suggested as a possible contributing factor, since
women seeking cosmetic implants have been shown to
have varying degrees of low self-esteem, anxiety and
depression, including severe depression or suicidal
thoughts [18–20]. However, whether the increased
suicide risk is due to predisposing characteristics or to
post-implant dissatisfaction cannot at the moment be
deciphered. Short-term complications associated with
breast implants are well recognized, and may be
enhanced among women receiving implants for
reconstructive purposes [21]. Some support for post-
implantation effects derives from studies in Denmark
which show that women seeking implants have similar
frequencies of prior depression than other patients [9], but
higher rates of post-implantation use of psychotropic
drugs [22]. Nonetheless, it would seem advisable that
women seeking implant surgery, regardless of whether for
cosmetic or reconstructive purposes, be appropriately
evaluated and counseled to ensure that they are properly
suited for the procedure.63
Conclusion
Although the results of this study shed some light on the
mortality experience of women seeking reconstructive
surgery after mastectomies, inabilities to account for a
variety of factors that could lead to a survival advantage in
these women necessitate cautious interpretation of the
results. Before concluding that breast implants have
beneficial effects on survival, additional studies are
needed that will permit a variety of lifestyle and disease
parameters to be fully taken into account. To shed further
light on this issue, an investigation of effects within the
context of breast cancer treatment trials seems warranted.
Alternatively, further insights might be derived from
comparing the mortality experience of women who opt for
reconstructive implants (either silicone or saline) versus
autologous tissue reconstruction. Given increased
recognition of the importance of reconstructive surgery in
improving the quality of life after a diagnosis of breast
cancer, it is hoped that further well-designed
investigations of survival patterns among women with
reconstructive implants will be undertaken.
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